Pds biotech to participate in the 2023 cantor fitzgerald global healthcare conference

Princeton, n.j., sept. 20, 2023 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb) (pds biotech or the company), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccines based on the company's proprietary t cell activating platforms, today announced that frank bedu-addo, phd, chief executive officer of pds biotech, will participate in a panel presentation at the 2023 cantor fitzgerald global healthcare conference being held september 26-28, 2023, in new york city. details for the event are as follows:
PDSB Ratings Summary
PDSB Quant Ranking